Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0757
D

Failure to Use Non-Pharmaceutical Interventions and Monitor Side Effects

West Grove, Pennsylvania Survey Completed on 06-13-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that non-pharmaceutical interventions were attempted prior to administering pain medication for one resident. Specifically, a resident with an order for Oxycodone 10 mg every eight hours as needed for moderate to severe pain received the medication on multiple occasions, but there was no evidence in the clinical record that non-pharmaceutical interventions were tried before administering the medication. This was confirmed by the Director of Nursing during an interview, who acknowledged that such interventions were not attempted prior to giving the pain medication. Additionally, the facility did not monitor for side effects during the use of anti-psychotic medication for another resident. This resident, diagnosed with Alzheimer's Dementia, unspecified mood disorders, and anxiety disorder, had an order for Quetiapine 25 mg at bedtime and received the medication daily. However, review of the Medication Administration Record and progress notes showed no documentation of side effect monitoring while the anti-psychotic was administered. The Director of Nursing confirmed in an interview that there was no documentation of side effect monitoring for this medication.

An unhandled error has occurred. Reload 🗙